-
EP0249613
European procedure
Extract from the Register of European Patents
EP About this file: EP0249613
| EP0249613 - INTERLEUKIN-4 PROTEIN HAVING BCGF AND TCGF ACTIVITY ON HUMAN CELLS (HUMAN INTERLEUKIN-4) [Right-click to bookmark this link] | |||
| Former [1987/52] | MAMMALIAN INTERLEUKIN-4 | ||
| [1996/27] | Status | No opposition filed within time limit Status updated on 09.05.1997 Database last updated on 14.06.2024 | Most recent event Tooltip | 09.05.1997 | No opposition filed within time limit | published on 25.06.1997 [1997/26] | Applicant(s) | For all designated states Schering Biotech Corporation 901 California Avenue Palo Alto California 94304-1104 / US | [N/P] |
| Former [1989/11] | For all designated states Schering Biotech Corporation 901 California Avenue Palo Alto California 94304-1104 / US | ||
| Former [1987/52] | For all designated states SCHERING-BIOTECH CORPORATION 901 California Avenue Palo Alto, CA 94304-1104 / US | Inventor(s) | 01 /
LEE, Frank 212 Rinconada Avenue Palo Alto, CA 94301 / US | 02 /
YOKOTA, Takashi 890 Colorado Avenue Palo Alto, CA 94303 / US | 03 /
ARAI, Ken-ichi 648 Georgia Avenue Palo Alto, CA 94306 / US | 04 /
MOSMANN, Timothy 69 Lloyden Drive Atherton, CA 94025 / US | 05 /
RENNICK, Donna 601 Almond Avenue Los Altos, CA 94022 / US | 06 /
SMITH, Craig 350 Franklin Street Mountain View, CA 94041 / US | [1987/52] | Representative(s) | Ritter, Stephen David, et al Mathys & Squire LLP 120 Holborn London EC1N 2SQ / GB | [N/P] |
| Former [1987/52] | Ritter, Stephen David, et al Mathys & Squire 100 Grays Inn Road London WC1X 8AL / GB | Application number, filing date | 86907184.5 | 19.11.1986 | [1987/52] | WO1986US02464 | Priority number, date | US19850799668 | 19.11.1985 Original published format: US 799668 | US19850799669 | 19.11.1985 Original published format: US 799669 | US19860843958 | 25.03.1986 Original published format: US 843958 | US19860881553 | 03.07.1986 Original published format: US 881553 | US19860908215 | 17.09.1986 Original published format: US 908215 | [1987/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO8702990 | Date: | 21.05.1987 | Language: | EN | [1987/11] | Type: | A1 Application with search report | No.: | EP0249613 | Date: | 23.12.1987 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.05.1987 takes the place of the publication of the European patent application. | [1987/52] | Type: | B1 Patent specification | No.: | EP0249613 | Date: | 03.07.1996 | Language: | EN | [1996/27] | Search report(s) | International search report - published on: | EP | 21.05.1987 | Classification | IPC: | C07K14/54, C12N15/70, A61K38/20 | [1996/27] | CPC: |
C07K16/247 (EP);
A61P37/04 (EP);
C07K14/5406 (EP);
C12N15/66 (EP);
C12N15/70 (EP);
C12N15/86 (EP);
|
| Former IPC [1987/52] | C07K15/00, C07K13/00, C12N15/00, C12P21/00, A61K37/02 | Designated contracting states | AT, BE, CH, DE, ES, FR, GB, GR, IT, LI, LU, NL, SE [1988/51] |
| Former [1987/52] | AT, BE, CH, DE, FR, GB, IT, LI, LU, NL, SE | Title | German: | INTERLEUKIN-4 PROTEIN MIT BCGF- UND TCGF-AKTIVITÄT GEGENÜBER MENSCHLICHEN ZELLEN (MENSCHLICHES INTERLEUKIN-4) | [1996/27] | English: | INTERLEUKIN-4 PROTEIN HAVING BCGF AND TCGF ACTIVITY ON HUMAN CELLS (HUMAN INTERLEUKIN-4) | [1996/27] | French: | INTERLEUKINE-4 PROTEINE AYANT UNE ACTIVITE BCGF AND TCGF VERS CELLULES HUMAINES (INTERLEUKINE-4 HUMAINE) | [1996/27] |
| Former [1987/52] | SÄUGETIER-INTERLEUKIN-4 | ||
| Former [1987/52] | MAMMALIAN INTERLEUKIN-4 | ||
| Former [1987/52] | INTERLEUKINE-4 MAMMIFERE | Miscellaneous | EPB 1988/52: Verbunden mit 86309041.1/0230107 (europäische Anmeldenummer/Veröffentlichungsnummer) durch Entscheidung vom 14.11.88 | EPB 1988/52: Consolidated with 86309041.1/0230107 (European application No./publication No.) by decision dated 14.11.88 | EPB 1988/52: Jointe à la demande no. 86309041.1/0230107 (numéro de dépôt/numéro de publication de la demande européenne) par décision du 14.11.88 | Entry into regional phase | 25.06.1987 | National basic fee paid | 28.11.1986 | Designation fee(s) paid | 25.06.1987 | Examination fee paid | Examination procedure | 26.06.1987 | Examination requested [1987/52] | 28.03.1990 | Despatch of a communication from the examining division (Time limit: M06) | 01.10.1990 | Reply to a communication from the examining division | 02.10.1991 | Despatch of a communication from the examining division (Time limit: M06) | 09.04.1992 | Reply to a communication from the examining division | 07.08.1992 | Despatch of a communication from the examining division (Time limit: M06) | 15.02.1993 | Reply to a communication from the examining division | 14.02.1994 | Despatch of a communication from the examining division (Time limit: M06) | 05.11.1994 | Reply to a communication from the examining division | 30.01.1995 | Despatch of a communication from the examining division (Time limit: M01) | 26.02.1995 | Reply to a communication from the examining division | 17.05.1995 | Despatch of communication of intention to grant (Approval: Yes) | 12.10.1995 | Communication of intention to grant the patent | 25.11.1995 | Fee for grant paid | 25.11.1995 | Fee for publishing/printing paid | Divisional application(s) | EP95108150.4 / EP0675136 | Opposition(s) | 04.04.1997 | No opposition filed within time limit [1997/26] | Request for further processing for: | 05.11.1994 | Request for further processing filed | 05.11.1994 | Full payment received (date of receipt of payment) Request granted | 21.11.1994 | Decision despatched | Fees paid | Renewal fee | 14.10.1988 | Renewal fee patent year 03 | 10.10.1989 | Renewal fee patent year 04 | 15.10.1990 | Renewal fee patent year 05 | 11.10.1991 | Renewal fee patent year 06 | 19.10.1992 | Renewal fee patent year 07 | 14.10.1993 | Renewal fee patent year 08 | 13.10.1994 | Renewal fee patent year 09 | 16.10.1995 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | WO8401504 [ ] (DANA FARBER CANCER INST INC [US]); | EP0138133 [ ] (SCHERING BIOTECH CORP [US]) | [A] - Proc. Natl. Acad. Sci. USA, 82, March 1985 J.J. MOND et al.: "Affinity Purified Interleukin 2 Induces Proliferation of Large but not Small B Cells", pages 1518-1521; see page 1518, Abstract and block 1, lines 37-43; block 2, lines 11-13; page 1521, block 1, lines 1-3, 41-45 | [A] - The Journal of Immunology, Vol. 134, No. 1, January 1985 C.B. THOMPSON et al.: "T Cell-Derived B Cell Growth Factors (s) can Induce Stimulation of Both Resting and Activated B Cells", pages 369-374, see page 373, block 1, lines 37-42 | Examination | - Proc. Natl. Acad. Sci. USA 83 (1986), 437 - 440 Science 231 (1986), 1118 - 1122 J. Exp. Med. 155 (1982), 914 - 923 |